about
Enhanced immunogenicity of a functional enzyme by T cell epitope modificationReceptor-binding domain-based subunit vaccines against MERS-CoVFolding of hepatitis C virus E1 glycoprotein in a cell-free system.Disease Prevention: An Opportunity to Expand Edible Plant-Based Vaccines?Expression library immunization: a road map for discovery of vaccines against infectious diseasesExploiting the yeast L-A viral capsid for the in vivo assembly of chimeric VLPs as platform in vaccine development and foreign protein expressionSevere acute respiratory syndrome (SARS) S protein production in plants: development of recombinant vaccineVaccine development in Staphylococcus aureus: taking the biofilm phenotype into consideration.Screening of 71 P. multocida proteins for protective efficacy in a fowl cholera infection model and characterization of the protective antigen PlpEEnhancement of humoral immune responses to HBsAg by heat shock protein gp96 and its N-terminal fragment in mice.Feasibility of Cowpea chlorotic mottle virus-like particles as scaffold for epitope presentations.Smallpox subunit vaccine produced in Planta confers protection in mice.Induction of cross-serovar protection against genital chlamydial infection by a targeted multisubunit vaccination approach.Self-adjuvanting bacterial vectors expressing pre-erythrocytic antigens induce sterile protection against malariaRecombinant vaccines and the development of new vaccine strategies.Artificially designed recombinant protein composed of multiple epitopes of foot-and-mouth disease virus as a vaccine candidate.The promise of reverse vaccinology.Outer membrane vesicles: an attractive candidate for pertussis vaccines.Optimization of a multi-stage, multi-subunit malaria vaccine candidate for the production in Pichia pastoris by the identification and removal of protease cleavage sites.PilVax - a novel peptide delivery platform for the development of mucosal vaccines.Immunological responses to recombinant cysteine synthase A of Brucella abortus in BALB/c mice.Microcrystalline Cellulose for Delivery of Recombinant Protein-Based Antigen against Erysipelas in Mice.Recent progress in microneme-based vaccines development against
P2860
Q24802822-C3238722-D274-4820-BB37-9CC6D1108B04Q26851979-24679D18-4548-4455-AB35-50FFFD636A7CQ27469881-7C678B42-AD43-49B1-8F84-9AE08F9BC524Q30234320-D50FD59C-63EC-424A-90F2-A881D0047E72Q33225644-C17D4F2D-5F79-471F-8BE3-8D77A5CBD638Q33283524-41377ECE-C3AC-47C0-9FBA-A392567F1758Q33863306-D4FF0290-9059-44C4-82B2-58FA826F8569Q34113328-39253E30-D236-4497-AFDC-11DC881B4EB9Q34335797-6FD91472-3B4A-4782-B4F0-CF1BD7E66A5FQ35010256-6FBE3CEB-43F8-4B23-9B71-35B873009BF0Q35756792-229BA717-BD18-4FDE-B790-D7FA13D3D6B6Q35800424-2C0DF18F-26F1-4177-9B14-F074000F69EBQ36314065-BC1FBD82-A908-493B-868D-EC5AEDF182B9Q36981626-B544F264-8788-4DE7-BB43-DDF582FA0EF3Q37370940-694EA7A1-6886-42E8-AF47-E7ADD95CC6F9Q37661480-C0585FD8-A9EA-4464-BDDA-3D709DAB373BQ38367088-DD44EDBC-725E-4ED4-A96D-E2BB22B838C5Q40410058-6BA43E88-21ED-4BE7-AE4E-8122D4C3FC78Q44941813-10963F5D-3689-45DE-B3C0-CE511F3BC482Q48507555-62B0DE07-F491-4DDB-9D52-DAE4A9D7DA79Q53127737-5FCE20AD-9EA2-4CE2-9ADD-6A0C8F48A6B3Q55501344-A23194A0-C76E-4CC4-A399-B3330456B273Q57177851-4C768626-6518-4A5A-AE2E-DC89D3FEA070
P2860
description
2000 nî lūn-bûn
@nan
2000 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Design and production of recombinant subunit vaccines.
@ast
Design and production of recombinant subunit vaccines.
@en
Design and production of recombinant subunit vaccines.
@nl
type
label
Design and production of recombinant subunit vaccines.
@ast
Design and production of recombinant subunit vaccines.
@en
Design and production of recombinant subunit vaccines.
@nl
prefLabel
Design and production of recombinant subunit vaccines.
@ast
Design and production of recombinant subunit vaccines.
@en
Design and production of recombinant subunit vaccines.
@nl
P356
P1476
Design and production of recombinant subunit vaccines
@en
P2093
P304
P356
10.1042/BA20000034
P577
2000-10-01T00:00:00Z